Public Citizen
Donate
Donate
American democracy is in jeopardy, from the disastrous Citizens United ruling that flooded our politics with corporate cash to the immoral assault on voting rights. We work every day to defend against these threats and advance bold reforms.
The U.S. government should work for the public, not corporations or industry. It should safeguard consumers, workers and the environment, and be funded well enough to do so. The budget process must not be obstructed by partisanship.
Every day, Big Banks, Big Tech, and their armies of corporate lobbyists threaten our economy, our financial security, and our democracy – sacrificing Main Street Americans and our families on the altar of corporate profits. Public Citizen advocates for ordinary people by taking on corporate interests and their cronies in government.
Prescription drugs are unaffordable and new drugs and devices often are approved without being proven safe and effective. Public Citizen challenges Big Pharma, device manufacturers and federal regulators to make drugs and medical devices safe, effective and accessible to all.
Health care in the U.S. leaves too many people out, costs too much and doesn’t meet acceptable standards of quality. Much of the care that we get is unaffordable, unnecessary or harmful. Public Citizen advocates Medicare for All, stronger oversight of dangerous doctors and safe clinical trials.
As Public Citizen’s division fighting for a fairer global economy, Global Trade Watch works to expose and challenge trade policies that put corporate profits over people.
Under Donald Trump, that mission faces a new urgency. Trump has won two elections in part by exploiting working people’s real frustrations about an increasingly complex and unequal global economy, yet his trade agenda serves only himself and his billionaire allies.
Global Trade Watch seeks to hold him accountable, resist corporate rollbacks, and advance a global trade vision that uplifts workers across borders.
Learn more about our work.
The climate crisis is the challenge of our time. We can fix it with solutions that will make us healthier and more economically secure. We must act quickly to make our economy run on renewable power — and ensure that disadvantaged families and displaced workers share equitably in the new economy. We also must fight the corrupting power of fossil fuel companies and ensure that energy regulators are effective and publicly accountable.
Litigation can remedy or deter wrongdoing, impact policy and meaningfully slow abuses of power. Whether suing on behalf of our members to ensure the honest functioning of government, or representing individual consumers seeking redress in court, our litigation draws on our expertise in administrative law, constitutional law, and government transparency.
Public Citizen News / March-April 2022
By David Rosen
This article appeared in the March/April 2022 edition of Public Citizen News. Download the full edition here.
It’s probably the most important legislation you’ve never heard of.
U.S. Rep. Pramila Jayapal (D-Wash.), chair of the Congressional Progressive Caucus, in December introduced the Stop Corporate Capture Act (H.R. 6107). This landmark legislation would strengthen one of the most crucial areas of federal policymaking – an area Public Citizen has fought for decades to reform: the rulemaking process.
Rulemaking is the process government agencies use to create regulatory protections for workers, consumers, civil rights, public health, and our environment. Not only are strong regulatory safeguards overwhelmingly popular with the public, they are the foundation of a sound economy, a livable planet, and a fair and equitable society.
“With Congress increasingly gridlocked and unable to pass legislation on the most pressing issues due to abuse of the U.S. Senate’s filibuster, many of the policies aimed at addressing big ticket crises like climate change, economic inequality, and protecting public health during the pandemic will have to be regulations,” said Lisa Gilbert, executive vice president of Public Citizen.
“We need a process for creating rules that works for the public, but that’s not what we currently have,” added Amit Narang, regulatory policy advocate for Public Citizen. “Right now, corporations completely dominate the rulemaking process. The problems are deep, structural, and longstanding, persisting no matter which party controls the White House.”
Numerous studies (some conducted by Public Citizen and its allies in the Coalition for Sensible Safeguards) have shown that corporate lobbyists hold more meetings with agency officials, submit more comments, and bring more legal challenges against regulations than public interest groups or ordinary citizens. Naturally this intensive lobbying and pressure results in more corporate-friendly rules.
The Stop Corporate Capture Act includes a series of bold and aggressive structural reforms that would 1) roll back corporate influence over the rulemaking process, 2) increase transparency around agency actions, 3) clear various industry-backed roadblocks and bottlenecks that thwart public protections, 4) empower the public to hold agencies accountable for enforcing the rules, and 5) build a foundation for including social equity considerations in rulemaking.
First, the legislation would ensure consumers, workers, and regular people get a seat at the rulemaking table by establishing an Office of the Public Advocate, which would be the voice of the public in the rulemaking process.
The Office of Public Advocate’s core mission would be to reduce corporate capture by increasing the influence of the public. It’s critical that agencies hear from those of us who would benefit from new regulatory protections – not just corporate lobbyists that want to dilute, delay, and deny stronger safeguards.
Second, the legislation would prevent corporations from misleading agencies or challenging agency science with bogus studies – a tactic repeatedly used by Big Tobacco, Big Oil, and others. Currently, corporations can submit comments on new regulations that include sham studies and reports without disclosing how they were funded.
The bill would require the disclosure of funding sources and any conflicts of interest connected to studies sent to agencies for consideration. In addition, agencies would be prohibited from considering studies that haven’t been peer reviewed and got 10% or more of their funding from regulated industries.
Relatedly, the bill would increase criminal penalties when corporations talk out of both sides of their mouths – exaggerating the costs of new regulations in comments to agencies, while privately telling shareholders these same regulations won’t be so costly.
Corporations have an incentive to inflate the costs when lobbying against regulations, but they’re legally obligated to be truthful with shareholders. Businesses need to be held accountable when they lie to regulators.
Third, the bill would remove loopholes and bottlenecks that corporations exploit to delay and block public protections.
For example, the bill would bring much-needed transparency and accountability to the U.S. Office of Information and Regulatory Affairs (OIRA) – the federal clearinghouse for regulatory activity – which historically has weakened and blocked new consumer, worker, and environmental protections in response to corporate lobbying.
The bill also would make rulemaking more efficient by putting OIRA on the clock to complete its regulatory reviews.
Fourth, the legislation would stop the U.S. Supreme Court from overturning new regulatory protections based on fringe legal doctrines, as the court recently did when it prevented the government from protecting workers against COVID.
The bill would make sure the Supreme Court follows the longstanding and commonsense principle that Congress passed laws giving agencies the authority to decide important policy matters – not the courts.
And finally, the bill would empower everyday Americans to bring citizen lawsuits holding government agencies accountable for failing to enforce the law when corporations get caught violating the rules.
Public Citizen and its allies are leading the push to bring more federal lawmakers on board, and educate them about the importance of a strong, efficient, and effective regulatory system. The Stop Corporate Capture Act already had 11 cosponsors in the U.S. House – including U.S. Reps. Alexandria Ocasio-Cortez (D-N.Y.), Ilhan Omar (D-Minn.), and Barbara Lee (D-Calif.) – with more likely on the way.
“The roadmap to improving and strengthening the regulatory process runs through the Stop Corporate Capture Act,” said Narang. “It’s time to fix the regulatory process by reducing corporate domination and increasing the influence of consumers, workers, and everyday Americans.”
Public Citizen News
Donate
Donate
Copyright © 2024 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen
holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This website is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.
Public Citizen is fighting, suing, and organizing against the Trump regime. Donate today to support our work.
Contribute Now
Leave a Reply